An explosion of new information linking activation of cell surface signal initiators to changes in gene expression has recently emerged. The focus of much of this information has centered around the agonist-dependent activation of the mitogen-activated protein (MAP) kinases. Although this intracellular signal transduction pathway is extremely complex, conservation of many of its components has been observed in yeast, nematodes, Drosophila, and mammals. Thus, these signaling proteins may participate in the regulation of a variety of cellular processes.
How cellular regulatory information generated at the plasma membrane as changes in protein-tyrosine phosphorylation is converted into altered proteinserine/threonine phosphorylation is of great interest in the cell-cycle field. One approach used to understand this process is to start with a defined, growthregulated phosphorylation event (e.g., the phosphorylation of the S6 protein of the 40S ribosomal subunit), identify its regulating kinase(s), and then work back to the original signal transducer. Several years ago an =90-kDa cell cycle-regulated S6 protein kinase (now referred to as ppgorsk or RSK) was identified and shown to be regulated by serine/threonine phosphorylation (for review see refs. 1 and 2). Soon after, a mitogenactivated protein kinase [referred to as MAP kinase or extracellular signalregulated kinase (ERK)] was identified that phosphorylated and partially reactivated dephosphorylated RSK (3). Excitement came when it was demonstrated that MAP kinases required tyrosine phosphorylation for activation (4) . That MAP kinase might be the "switch kinase" responsible for tyrosine-to-serine/ threonine phosphorylation was appealing and amazingly simple. However, any pathway potentially important in the regulation of cell proliferation is likely to be complex and to contain many checks and balances. A flurry of reports in the last year demonstrated just that. Here I discuss some of these studies, with their various caveats, that provide new information aiding in the further biochemical and molecular dissection of the complex signaling systems regulating MAP kinases and RSK.
The observation that protein-tyrosine kinases such as the insulin receptor and v-Src were unable to activate MAP kinase in vitro suggested that MAP kinases might not be the switch kinases as originally believed and that there were additional signaling molecules between MAP kinases and the receptor tyrosine kinases (for review see refs. [5] [6] [7] [8] . The purification and cloning of a growth-regulated MAP kinase/ERK-activating kinase (referred to here as MEK; see ref. 9), which exhibited dual specificity (capable of phosphorylating both tyrosine and serine/threonine), strengthened this concept (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) . Surprisingly, MEK was shown to be regulated by serine/threonine phosphorylation (11, 14, 18) . Although the identification of MEK brings us a step closer in the signaling pathway to receptor tyrosine kinases, it also indicates additional intervening steps in the molecular link between tyrosine and serine/threonine phosphorylation. The complexity of the MAP kinase/RSK signaling system became more apparent when several laboratories demonstrated that c-Ras mediates transmission of activating information from receptor tyrosine kinases to the MAP kinases (20) (21) (22) (23) (24) (25) (26) .
One of these studies also demonstrated that c-Raf is downstream of c-Ras (23) . Evidence that c-Raf might be the kinase responsible for activation of MEK was subsequently presented (27) (28) (29) . With this information, these enzymes can be arranged into a linear pathway in which an activated cytoplasmic or receptor tyrosine kinase indirectly activates c-Ras, which leads to the activation of c-Raf, then MEK, then MAP kinase, then RSK, finally resulting in increased S6 phosphorylation. Unfortunately, it is not so simple ( Fig. 1 (37) , and a growth-regulated protein kinase activity which was distinct from the MAP kinases but capable of phosphorylating recombinant RSK in vitro has been detected (36) . Further support for the existence of additional RSKkinase activities comes from experiments using chicken embryo fibroblasts expressing a temperature-sensitive transformation mutant of v-Src. After activation of v-Src by transfer of cells to the permissive temperature, RSK (unlike the MAP kinases) undergoes two distinct activation phases. The early, transient activation of RSK is coordinate with the activation of MAP kinases, but the prolonged, late RSK activation is coordinate with activation of a 63-kDa protein-serine kinase that phosphorylates myelin basic protein (38) . Like ERKs 1 and 2 [the predominant MAP kinase isoforms in most animal cells (6, 39) ], this 63-kDa enzyme may be involved in the regulation of RSK. Whether this 63-kDa enzyme is related to the as yet unidentified erk-3 gene product (39) and/or regulated by a mechanism different from that of ERKs 1 and 2 remains to be determined.
The fact that MEK potently activates MAP kinase in vitro supports a direct link between MEK and the MAP kinases (10) (11) (12) 17 (27) (28) (29) , it may not be the growth factorregulated activator of MEK in all circumstances. Evidence that c-Raf mediates signaling from c-Ras to MEK/MAP kinase includes Drosophila genetic studies (43, 44) , in vitro reactivation experiments (27) (28) (29) , and baculovirus expression studies in insect cells (45) . However, other results indicate that c-Raf may not directly phosphorylate and/or be the sole activator of MEK. First, in rat PC12 pheochromocytoma cells, inducible expression of activated Raf does not result in significant activation of MAP kinase and RSK, whereas the same experiment using inducible expression of activated Ras does (23) . Second, v-Raf-transformed Rat-1 fibroblasts do not exhibit activated MAP kinase, whereas v-Raftransformed NIH 3T3 mouse cells do (46) . Third, c-Raf hyperphosphorylation (frequently employed to indicate c-Raf activation) does not correlate with the rapid phosphorylation/dephosphorylation (activation/inactivation) of MAP kinases in PC12 cells (23) , and although c-Raf is phosphorylated and activated in murine interleukin-2-dependent T cells (47, 48) , MAP kinase and RSK are not (49, 50 (51) . It is noteworthy that 3CH134 protein expression is coordinate with inactivation of MAP kinase activity following mitogen stimulation in 3T3 cells. In Schizosaccharomyces pombe, a cellular inhibitor (the mei3+ gene product) regulates the ranl+ kinase, which mediates signal transduction from rasl to byrl (52) (24, 25) . However, activation of MAP kinases may not be entirely Ras-dependent and, like Raf, may exhibit some cell-type specificity. For example, in rat PC12 cells activation of MAP kinases via phorbol ester-dependent activation of protein kinase C was blocked by (S17N)Ras (22, 23) or by overexpression of GTPaseactivating protein (26) . However, protein kinase C-dependent activation of MAP kinase was not antagonized by (S17N)Ras in Rat-1 fibroblasts (20) . Similarly, blocking Ras activation does not effect G protein (AIFZ)-mediated activation of MAP kinase (21, 26) . However, signal transduction by a Pertussis toxinsensitive heterotrimeric Gi protein is mediated by Ras (46, 56) , and Ras activation by Gi requires activation of an intermediate protein-tyrosine kinase (56) . Thus, even G protein-mediated signaling to the MAP kinases can occur through Rasdependent and -independent pathways. These data are also consistent with the possibility that MEKK and c-Raf can work independently or together to activate MEK by various agonists.
Because of the importance of Ras in normal cell proliferation, differentiation, and tumorigenesis, the mechanism by which it is activated and then transmits information is the subject of intense study. In addition to yeast and Drosophila genetics, the use of Xenopus oocyte cell-free extracts to study signaling to MAP kinase may provide yet another system for biochemically teasing out the Ras regulators and effectors. Cell-free extracts from G2/M-arrested oocytes retain the capacity to respond to cell-cycle activators, including activated Ras, cyclin A, and cyclin B, as assessed by activation of MAP kinase activity (57) (58) (59) . Such a system can be used to monitor the ability of other putative growthregulating molecules to modulate the MAP kinase signaling pathways. For example, genetic and biochemical evidence supports the notion that CDC25-like guanine nucleotide exchange factors (similar to the product of the Drosophila gene Son-of-sevenless, Sos) are important in signal transduction from tyrosine kinases to Ras (60, 61) . Using other approaches, several laboratories have now provided evidence that a mammalian Sos does indeed regulate Ras signaling (72) . Similarly, SH-PTP2 (an SH2-containing protein-tyrosine phosphatase similar to the product of the Drosophila gene corkscrew) may act in concert with Raf in signal transduction by receptor tyrosine kinases (62, 63) . The ability of these and other proteins (like the SH2/SH3-adaptor proteins discussed below) to regulate MAP kinase activity may be tested and/or confirmed in the Xenopus cellfree system by simply pipeting in the activated proteins. Similarly, the need for Ras, Raf, or other signaling proteins in the transduction system can be monitored with the addition of dominant interfering mutant proteins or with affinitypurified neutralizing antibodies. Further, a variety of pharmacological reagents may be useful to dissect these pathways in in vitro and in vivo systems. The cellfree extract system may also be amenable for use as an assay system for the purification of novel participants (both upstream and downstream of Ras) in the pathway(s) regulating MAP kinase. A preliminary study using this assay system has provided evidence for a novel protein factor for p2lras-dependent activation of MAP kinase (59 As indicated by the title of this review, there is great risk in trying to describe the ever-expanding, complex signaling network involved in the regulation of MAP kinases. Fig. 1 
